ClinicalTrials.gg
Not yet recruitingNCT07784439Updated Aug 25, 2026

Breastfeeding Stories and Video Education in Primiparous Mothers

An interventional study of Routine Breastfeeding Education with Audio Stories and Video Education in Breastfeeding Self-Efficacy and Breastfeeding, sponsored by Yeditepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Yeditepe University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The Effect of Successful Breastfeeding Stories and Video-Based Education on Breastfeeding Self-Efficacy and Breastfeeding Success in Primiparous Mothers: A Randomized Controlled Trial

Objective: This study was planned to determine the effect of the combined use of audio recordings based on successful breastfeeding stories and video-based breastfeeding education on breastfeeding self-efficacy and breastfeeding success among primiparous mothers.

Methods: This study will be conducted using a randomized controlled experimental design. The population of the study will consist of primiparous mothers who give birth at the Obstetrics and Gynecology Clinic of Koç University Hospital between September 2026 and February 2027. The sample will consist of a total of 70 primiparous mothers (35 intervention and 35 control) who meet the inclusion criteria and are assigned to the intervention and control groups using a computer-assisted simple randomization method. In addition to routine breastfeeding education provided at the hospital, mothers in the intervention group will receive audio recordings based on successful breastfeeding stories and video-based breastfeeding education. The control group will receive only the routine breastfeeding education provided at the hospital. Data will be collected using the Descriptive Characteristics Form, Postpartum Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), LATCH Breastfeeding Assessment Tool, Educational Materials Satisfaction Form, and First-Month Evaluation Form. Data will be analyzed using SPSS version 25.0. Descriptive statistics, independent-samples t-test, paired-samples t-test, chi-square test, and repeated-measures analysis of variance (ANOVA) will be used. The statistical significance level will be accepted as p\<0.05.

Expected Results: It is anticipated that the audio recordings based on successful breastfeeding stories and the video-based education program will increase breastfeeding self-efficacy and breastfeeding success among primiparous mothers.

Conclusion: The findings obtained from this study are expected to contribute to the planning of evidence-based nursing interventions aimed at improving breastfeeding self-efficacy and breastfeeding success among primiparous mothers, provide a scientific basis for innovative educational models that can be used to support breastfeeding, and guide the development of standardized breastfeeding education programs that can be implemented in postpartum care services.

02

Conditions studied

  • Breastfeeding Self-Efficacy
  • Breastfeeding

Browse trials for

Keywords

  • Primiparous mother
  • video-based education
  • successful breastfeeding story
  • randomized controlled trial
  • LATCH
  • BSES-SF
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 70 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

Yeditepe University is the lead sponsor of 131 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Able to read and write in Turkish
  • Being primiparous
  • Having given birth to a singleton live birth at >37 weeks of gestation
  • Absence of any medical conditions hindering breastfeeding
  • Able to use a smartphone
  • Voluntary agreement to sign written
  • Having a healthy newborn
  • Presence of the sucking reflex in the infant
  • Absence of neonatal intensive care unit (NICU) admission requirement

Exclusion criteria

Exclusion Criteria:

  • Withdrawal of consent / wishing to leave the study
  • Incomplete completion of data collection tools
  • Infant experiencing severe health issues requiring hospital readmission
  • Loss of contact during the follow-up period
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants will receive routine hospital breastfeeding education along with audio recordings of successful breastfeeding stories and video-based education.

    Behavioral: Routine Breastfeeding Education with Audio Stories and Video Education

  • No intervention
    control group

    Participants will receive only routine hospital breastfeeding education.

Interventions

  • BehavioralRoutine Breastfeeding Education with Audio Stories and Video Education

    In addition to the routine breastfeeding education provided by the hospital, participants in this group receive audio recordings based on successful breastfeeding stories and video-based breastfeeding education.

06

What researchers measure

Primary outcomes

  1. Breastfeeding Self-Efficacy Scale Short Form (BSES-SF) Score

    Assessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF). Total scores range from 14 to 70, with higher scores indicating higher levels of breastfeeding self-efficacy.

    Time frame: Baseline (within first 24 hours postpartum) and Postpartum 1st Month (Day 30)

  2. LATCH Breastfeeding Assessment Tool Score

    Evaluates breastfeeding performance across 5 parameters (Latch, Audible swallowing, Type of nipple, Comfort, Hold). Total scores range from 0 to 10, with higher scores indicating higher breastfeeding success.

    Time frame: Baseline (within first 24 hours postpartum) and Discharge day (Day 2-3)

Secondary outcomes

  1. First-Month Evaluation Form

    Administered by the researcher via phone or online communication methods at the 1st month postpartum. The researcher reads the questions to the participant without guidance and records the responses to evaluate breastfeeding status and outcomes.

    Time frame: Postpartum 1st Month (Day 30)

  2. Education Satisfaction Form Score

    Evaluates the participants' level of satisfaction with the educational materials provided. Assessed using a structured questionnaire.

    Time frame: Discharge day (Day 2-3)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2026
First posted
Aug 25, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Jun 1, 2027
CompletionEst.
Jun 1, 2027
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07784439
Responsible party
Sponsor
First posted
Aug 25, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Berfin Aydın, BSc
Contact
aydiinberfin@gmail.com
+90 539 894 91 77

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion